Harpoon Therapeutics Profit Margin

The latest profit margin for HARP is -83.58% as of September 2023. That compares with -220.41% in the prior-year period — up 62.1% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Harpoon Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, HARP's profit margin moved from -220.41% to -83.58% — a 62.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harpoon Therapeutics's valuation or profitability profile.

Against Healthcare companies, HARP currently prints -83.58% for profit margin, while the sector average sits near 15.29%. That is roughly 646.5% below the sector mean. Large gaps often invite a closer look at Harpoon Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Harpoon Therapeutics converts resources into returns. At -83.58%, HARP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -220.41% in the prior-year period — up 62.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HARP's profit margin (-83.58%), review year-over-year change from -220.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.